AAV9

AAV9 Product List

  • Product Category

    Kits (3)Antibody (1)

  • Product Status

    Launched (4)

  • Species

    Mouse (2)AAV (2)

  • Tag

    - (4)

  • Conjugate

    - (3)Unconjugated (1)

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
TR-987Z-101; GLYC-101; MG-3601Phase 3 ClinicalKazia TherapeuticsVaricose Veins; Wounds and Injuries; Varicose Ulcer
Details
Monovalent norovirus Vaccine (Vaxart)VXA-G1-1-NN; VXA-G1.1-NNPhase 2 ClinicalVaxart IncNorovirus Infections
Details
Poly ICLC (Oncovir)Phase 2 ClinicalNational Institutes Of Health, Oncovir IncSarcoma; Carcinoma, Non-Small-Cell Lung; Melanoma; Metastatic breast cancer; Lymphoma, T-Cell; Glioma; Carcinoma, Squamous Cell; Colorectal Neoplasms; Prostatic Neoplasms; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Lymphoma, B-Cell; Osteosarcoma; Urinary Bladder Neoplasms; Mesothelioma; Pancreatic Neoplasms; Coronavirus Disease 2019 (COVID-19); Glioblastoma; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; HIV Infections
Details
BO-112BO-112Phase 2 ClinicalNeoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Colorectal Neoplasms; Neurofibrosarcoma; Sarcoma; Sarcoma, Synovial; Liposarcoma; Leiomyosarcoma; Dermatofibrosarcoma; Stomach Neoplasms; Histiocytoma, Malignant Fibrous; Retroperitoneal Neoplasms; Esophageal Neoplasms; Carcinoma, Basal Cell; Fibrosarcoma; Rhabdomyosarcoma
Details
Monovalent norovirus Vaccine (Vaxart)/VXA-G2-4-NSVXA-NVV-201Phase 2 ClinicalVaxart IncNorovirus Infections
Details
CNTO-5CNTO-5Phase 1 ClinicalInflammation
Details
PGV-001PGV-001Phase 1 ClinicalGenentech Inc, Icahn School Of Medicine At Mount SinaiNeoplasms; Urologic Neoplasms
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
RintatolimodAMP-516; AMP-518ApprovedHemispherx Biopharma IncRintamod, AmpligenArgentinaFatigue Syndrome, ChronicHemispherx Biopharma Inc2017-01-01HIV Infections; Ovarian Neoplasms; Pancreatic Neoplasms; Mesothelioma; Influenza, Human; Post-Acute COVID-19 Syndrome; Breast Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Fatigue Syndrome, Chronic; HIV Seropositivity; Breast Neoplasms, Male
Details
  • Product List
  • Marketed Drug Information
  • Clinical Drug Information